Roche’s New Diabetes Drug Works Better Than Byetta – Wall Street Journal
 Reuters India |
Roche's New Diabetes Drug Works Better Than Byetta
Wall Street Journal VX) said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. (LLY) in lowering blood sugar, … UPDATE 2-Ipsen ups margin goal, diabetes drug hits test targetReuters Roche diabetes drug beats ByettaFierceBiotech Roche: Taspoglutide Meets Endpoint In Type 2 Diabetes TrialsCapital.gr (press release) Genetic Engineering News (press release) -WELT ONLINE -Pharma Times all 43 news articles » |
Mail this postOther articles you might like;
- Diabetes - Women With Polycystic Syndrome - Role of Exercise
- Diabetes Management - Role of Family
- Diabetic Cures - The Promise and the Reality of Controlling Diabetes
- Homeopathic Remedies For Diabetes - Principles of Homeopathy
- Type 2 Diabetes Natural Remedies - Tell Me What I Do Not Know Yet About Diabetes
Leave a Reply
